Clinical Study
Intravenous Infusion of Dexmedetomidine Combined
Isoflurane Inhalation Reduces Oxidative Stress and
Potentiates Hypoxia Pulmonary Vasoconstriction during
One-Lung Ventilation in Patients
Rui Xia,
1
Jinjin Xu,
2
Hong Yin,
1
Huozhi Wu,
3
Zhengyuan Xia,
4,5,6
Daiwei Zhou,
7
Zhong-yuan Xia,
2
Liangqing Zhang,
5,6
Haobo Li,
5,6
and Xiaoshan Xiao
7
1
Department of Anesthesiology, First Afliated Hospital, Yangtze University, Jingzhou 434000, China
2
Department of Anesthesiology, Wuhan University Renmin Hospital, Wuhan 430060, China
3
Department of Cardiothoracic Surgery, Fifh Afliated Hospital of Zunyi Medical College, Zhuhai 519100, China
4
Department of Anesthesiology, Te Second Afliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University,
Wenzhou, Zhejiang 325000, China
5
Department of Anesthesiology, Afliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China
6
Department of Anesthesiology, Te University of Hong Kong, Hong Kong
7
Department of Anesthesiology, Guangdong No. 2 Provincial People’s Hospital, Guangdong Provincial Emergency Hospital,
Guangzhou, Guangdong 510317, China
Correspondence should be addressed to Zhengyuan Xia; zhengyuan xia@yahoo.com and Xiaoshan Xiao; gd177mzk@163.com
Received 7 January 2015; Accepted 13 February 2015
Academic Editor: Huang-Ping Yu
Copyright © 2015 Rui Xia et al. Tis is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Inhalation anesthetic isofurane inhibits hypoxia pulmonary vasoconstriction (HPV), while dexmedetomidine (Dex) could reduce
the dose of isofurane inhalation and potentiate HPV, but the mechanism is unclear. Inhibition of reactive oxygen species
(ROS) production can favor HPV during one-lung ventilation (OLV). Similarly, nitric oxide (NO), an important endothelium-
derived vasodilator in lung circulation, can decrease the regional pulmonary vascular resistance of ventilated lung and reduce
intrapulmonary shunting. We hypothesized that Dex may augment HPV and improve oxygenation during OLV through inhibiting
oxidative stress and increasing NO release. Patients undergoing OLV during elective thoracic surgery were randomly allocated to
either isofurane + saline (NISO, = 24) or isofurane + dexmedetomidine (DISO, = 25) group. Anesthesia was maintained with
intravenous remifentanil and inhalational isofurane (1.0–2.0%), with concomitant infusion of dexmedetomidine 0.7 gkg
−1
h
−1
in DISO and saline 0.25 mL kg
−1
h
−1
in NISO group. Hemodynamic variables or depth of anesthesia did not signifcantly difer
between groups. Administration of Dex signifcantly reduced Qs/Qt and increased PaO
2
afer OLV, accompanied with reduced
lipid peroxidation product malondialdehyde and higher levels of SOD activity as well as serum NO (all < 0.05 DISO versus
NISO). In conclusion, reducing oxidative stress and increasing NO release during OLV may represent a mechanism whereby Dex
potentiates HPV.
1. Introduction
With the popularity of video-assisted thoracic surgery, the
requirement for one-lung ventilation (OLV) has been increas-
ing. OLV is used to provide a good surgical feld and
protect normal lungs from hemorrhage or abscess caused
by afected lung [1]. However, OLV can induce ventilation-
perfusion mismatch and pulmonary arteriovenous shunt in
the nonventilated lung that can cause hypoxemia [2]. Hypoxic
pulmonary vasoconstriction (HPV) is an important protec-
tive mechanism by which blood fow is diverted from the
nonventilated lung toward a better ventilated region, thereby
Hindawi Publishing Corporation
Mediators of Inflammation
Volume 2015, Article ID 238041, 7 pages
http://dx.doi.org/10.1155/2015/238041